Morphotonics invests in Ernij Next
Funding Provisional 85% confidence first seen
Morphotonics participated in a Series B funding round that raised more than €40 million to scale its nanoimprint lithography manufacturing technology for waveguides used in AI glasses and other photonic components. The round included participation from Ernij Next (alongside investors such as Invest-NL, the EIC Fund, and the EIB). This matters as the funding is intended to expand production capacity for Morphotonics’ Cypris platform and scale manufacturing for consumer-electronics optical components.
The deal
Morphotonics €40M+ Series B · announced 22 Sep 2026
Investors Invest-NL European Investment Bank EIC Fund Ernij Next EIB
Deal terms as reported in the coverage below.
Decision brief
- What changed
- Morphotonics raised more than €40 million in a Series B round, with participation from Ernij Next alongside Invest-NL, the EIC Fund, and the EIB. The company said it will use the funding to expand production capacity for its Cypris nanoimprint lithography platform used to manufacture waveguides for AI glasses and other photonic components.
- Why it matters
- For leaders evaluating AI-device and photonics supply chains, this financing indicates additional capacity is being built around a manufacturing step that the coverage describes as a bottleneck for optical components. It also suggests Morphotonics is moving from technology development toward scaled production, which could affect sourcing options, partnership timing, and component availability for consumer-electronics programs that depend on waveguides or related photonic parts.
- Evidence
- The claims are supported by Tech.eu’s reporting that Morphotonics closed a €40M+ Series B and plans to use the capital to expand Cypris production capacity, grow teams, and build supplier and support infrastructure. Only one cited article is provided, so the funding amount, investor participation, and stated use of proceeds come from a single outlet relaying the company’s announced plans.
- What remains uncertain
- The coverage does not specify expected capacity increases, production timelines, customer commitments, or whether the new funding will materially reduce lead times or costs for buyers. It also does not verify how quickly Morphotonics can convert capital into reliable high-volume output, so any procurement or partnership implications remain assumptions until execution milestones are disclosed.
- Monitor next
- Watch for disclosed production-capacity milestones, customer wins, or supplier agreements tied to the Cypris platform that show the Series B is translating into manufacturable volume.
Analytical support, not advice — assumptions and open questions stated above.